Advertisement

Search Results

Advertisement



Article Topics

Your search for Edward S. Kim, MD matches 1 pages

Showing 1 - 1


lung cancer

No Benefit From Adding Cetuximab to Pemetrexed in Recurrent/Progressive NSCLC After Platinum-Based Therapy

In a phase III trial reported in The Lancet Oncology, Edward S. Kim, MD, of Levine Cancer Institute, Carolinas HealthCare System, and colleagues investigated whether the addition of cetuximab (Erbitux) to pemetrexed (Alimta) improved progression-free survival in patients with recurrent or...

Advertisement

Advertisement



Advertisement